Skip to main content
The Globe and Mail
Get full access to globeandmail.com
Support quality journalism
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
The Globe and Mail
Support quality journalism
Get full access to globeandmail.com
Globe and Mail website displayed on various devices
Just$1.99
per week
for the first 24 weeks

var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){console.log("scroll");var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))}pencilInit(".js-sub-pencil",!1);

A young girl with malaria rests in the inpatient ward of the Malualkon Primary Health Care Center in Malualkon, in the South Sudanese state of Northern Bahr el Ghazal, June 1, 2012. A British drug firm’s clinical trials have moved the prospect of a malaria vaccine closer to market.

ADRIANE OHANESIAN/REUTERS

Canada is increasing its contribution to the Global Fund established to fight HIV/AIDS, malaria and tuberculosis by more than 20 per cent.

That will bring this country's new commitment to the fund to $650-million over three years – up from $500-million – at a time when experts say the fight against HIV/AIDS, in particular, is reaching a tipping point and a million new HIV infections annually could be averted through rapid scale-up of antiretroviral therapy.

"Our government is proud to stand with the Global Fund so that the next generation will not have to face the devastation caused by HIV, tuberculosis and malaria," Christian Paradis, the Minister for International Development, said Monday in announcing the commitment.

Story continues below advertisement

"Canada will continue to set ambitious goals and, with the help of partners such as the Global Fund, we will continue to achieve them," said Mr. Paradis.

The Global Fund has asked for a combined commitment from all the world's nations of $15-billion (all figures in U.S. dollars) to carry it through to 2016.

Countries including France, Germany, Switzerland and the Nordic nations have already made pledges. The U.S. said in April that it would give $1.65-billion a year, which amounts to about $5.21 annually per person in that country. And the United Kingdom said that it would give up to $533-million every year. That's more than $8 annually for each U.K. resident.

Canada was slow to step up to the plate. But aid groups say they are pleased with the commitment. The money is part of the G8 Muskoka Initiative announced three years ago by Prime Minister Stephen Harper to improve outcomes for maternal and child health.

Amy Bartlett, the executive director of Results Canada, told reporters that her group and others were "very pleased."

With "the increased contribution by the Canadian government for the world's poorest," said Ms. Bartlett, "they will not have access to the life-saving treatments and interventions that they need."

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies